NUS Historical Cash Flow
| NUS Stock | USD 7.69 0.25 3.36% |
Analysis of Nu Skin cash flow over time is an excellent tool to project Nu Skin Enterprises future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 47.6 M or Dividends Paid of 54.2 M as it is a great indicator of Nu Skin ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Nu Skin Enterprises latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nu Skin Enterprises is a good buy for the upcoming year.
NUS |
About NUS Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in NUS balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which NUS's non-liquid assets can be easily converted into cash.
Nu Skin Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Nu Skin Enterprises to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Nu Skin operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Nu Skin Enterprises financial statement analysis. It represents the amount of money remaining after all of Nu Skin Enterprises operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Change Receivables
The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.Most accounts from Nu Skin's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nu Skin Enterprises current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. At this time, Nu Skin's Total Cash From Operating Activities is comparatively stable compared to the past year. Total Cash From Financing Activities is likely to gain to about 11.3 M in 2024, despite the fact that Change In Cash is likely to grow to (8.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Dividends Paid | 76.3M | 77.0M | 77.6M | 54.2M | Depreciation | 76.3M | 72.5M | 70.9M | 47.6M |
Nu Skin cash flow statement Correlations
Click cells to compare fundamentals
Nu Skin Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nu Skin cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 18.4M | (31.1M) | (95.3M) | 40.3M | (13.2M) | (13.9M) | |
| Change In Cash | (51.3M) | 67.1M | (63.1M) | (74.9M) | (8.7M) | (8.2M) | |
| Free Cash Flow | 111.9M | 315.3M | 73.0M | 49.0M | 60.1M | 57.1M | |
| Change In Working Capital | (132.4M) | 52.6M | (193.6M) | (92.7M) | (81.7M) | (77.6M) | |
| Begin Period Cash Flow | 386.9M | 335.6M | 402.7M | 339.6M | 264.7M | 240.1M | |
| Other Cashflows From Financing Activities | 142.7M | 120.8M | 168.9M | 482.0M | 4.6M | 4.3M | |
| Depreciation | 76.7M | 74.0M | 76.3M | 72.5M | 70.9M | 47.6M | |
| Dividends Paid | 82.2M | 78.4M | 76.3M | 77.0M | 77.6M | 54.2M | |
| Capital Expenditures | 66.1M | 63.8M | 68.6M | 59.1M | 58.5M | 52.5M | |
| Total Cash From Operating Activities | 177.9M | 379.1M | 141.6M | 108.1M | 118.6M | 174.4M | |
| Net Income | 173.6M | 191.4M | 147.3M | 104.8M | 8.6M | 8.2M | |
| Total Cash From Financing Activities | (154.8M) | (245.2M) | (104.7M) | (99.5M) | 10.7M | 11.3M | |
| End Period Cash Flow | 335.6M | 402.7M | 339.6M | 264.7M | 256.1M | 248.8M | |
| Other Non Cash Items | 48.3M | 49.1M | 82.6M | 62.7M | 123.2M | 129.4M | |
| Sale Purchase Of Stock | (825K) | (144.3M) | (80.4M) | (70.0M) | (13.0M) | (13.7M) | |
| Change To Account Receivables | 2.7M | (11.2M) | 20.2M | (11.4M) | (22.7M) | (21.5M) | |
| Other Cashflows From Investing Activities | (8.1M) | (14.9M) | (19.0M) | (8.0M) | (7.2M) | (7.6M) | |
| Stock Based Compensation | 9.9M | 24.1M | 23.2M | 12.4M | 15.6M | 14.2M | |
| Change To Liabilities | (69.1M) | 126.7M | (113.9M) | (127.4M) | (114.7M) | (108.9M) | |
| Change Receivables | 2.7M | (11.2M) | 20.2M | (11.4M) | (13.2M) | (12.5M) | |
| Net Borrowings | (69.5M) | (27.5M) | 40M | 22.4M | 20.2M | 14.3M | |
| Total Cashflows From Investing Activities | (71.4M) | (79.4M) | (88.7M) | (67.1M) | (77.1M) | (81.0M) | |
| Exchange Rate Changes | (16.8M) | (3.0M) | 12.5M | (11.2M) | (12.9M) | (13.6M) | |
| Cash And Cash Equivalents Changes | (51.3M) | 67.1M | (63.1M) | (58.5M) | (52.7M) | (50.0M) | |
| Cash Flows Other Operating | (40.1M) | 14.4M | 26.0M | 50.4M | 57.9M | 60.8M | |
| Change To Netincome | 15.7M | 15.1M | 81.0M | (21.1M) | (24.2M) | (23.0M) | |
| Investments | 2.7M | (656K) | (1.1M) | (8.0M) | (132.5M) | (125.9M) | |
| Change To Operating Activities | (146.4M) | 70.1M | (105.2M) | (130.8M) | (150.4M) | (157.9M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.